Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56401 - 56425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	MVB12A	93343	downregulated	panobinostat results in decreased expression of MVB12A mRNA	19p13.11	A21037
Panobinostat	Approved Investigational	MXRA7	439921	downregulated	panobinostat results in decreased expression of MXRA7 mRNA	17q25.1	A21037
Panobinostat	Approved Investigational	MYCN	4613	upregulated	panobinostat results in increased expression of MYCN mRNA	2p24.3	A21037
Panobinostat	Approved Investigational	MYLIP	29116	upregulated	panobinostat results in increased expression of MYLIP mRNA	6p22.3	A21037
Panobinostat	Approved Investigational	MYLK	4638	downregulated	panobinostat results in decreased expression of MYLK mRNA	3q21.1	A21037
Panobinostat	Approved Investigational	MYO1D	4642	upregulated	panobinostat results in increased expression of MYO1D mRNA	17q11.2	A21037
Panobinostat	Approved Investigational	MYOCD	93649	upregulated	panobinostat results in increased expression of MYOCD mRNA	17p12	A21037
Panobinostat	Approved Investigational	MYOF	26509	upregulated	panobinostat results in increased expression of MYOF mRNA	10q23.33	A21037
Panobinostat	Approved Investigational	NABP1	64859	upregulated	panobinostat results in increased expression of NABP1 mRNA	2q32.3	A21037
Panobinostat	Approved Investigational	NANOG	79923	upregulated	panobinostat results in increased expression of NANOG mRNA	12p13.31	A21037
Panobinostat	Approved Investigational	NANOS1	340719	downregulated	panobinostat results in decreased expression of NANOS1 mRNA	10q26.11	A21037
Panobinostat	Approved Investigational	NANS	54187	upregulated	panobinostat results in increased expression of NANS mRNA	9q22.33	A21037
Panobinostat	Approved Investigational	NAV1	89796	downregulated	panobinostat results in decreased expression of NAV1 mRNA	1q32.1	A21037
Panobinostat	Approved Investigational	NAV3	89795	upregulated	panobinostat results in increased expression of NAV3 mRNA	12q21.2	A21037
Panobinostat	Approved Investigational	NCALD	83988	downregulated	panobinostat results in decreased expression of NCALD mRNA	8q22.3	A21037
Panobinostat	Approved Investigational	NCOA7	135112	downregulated	panobinostat results in decreased expression of NCOA7 mRNA	6q22.31-q22.32	A21037
Panobinostat	Approved Investigational	NDP	4693	downregulated	panobinostat results in decreased expression of NDP mRNA	Xp11.3	A21037
Panobinostat	Approved Investigational	NDUFB1	4707	downregulated	panobinostat results in decreased expression of NDUFB1 mRNA	14q31.3	A21037
Panobinostat	Approved Investigational	NEAT1	283131	upregulated	panobinostat results in increased expression of NEAT1 mRNA	11q13.1	A21037
Panobinostat	Approved Investigational	NEFL	4747	upregulated	panobinostat results in increased expression of NEFL mRNA	8p21.2	A21037
Panobinostat	Approved Investigational	NEFM	4741	upregulated	panobinostat results in increased expression of NEFM mRNA	8p21.2	A21037
Panobinostat	Approved Investigational	NEGR1	257194	upregulated	panobinostat results in increased expression of NEGR1 mRNA	1p31.1	A21035
Panobinostat	Approved Investigational	NELL1	4745	upregulated	panobinostat results in increased expression of NELL1 mRNA	11p15.1	A21037
Panobinostat	Approved Investigational	NELL2	4753	downregulated	panobinostat results in decreased expression of NELL2 mRNA	12q12	A21037
Panobinostat	Approved Investigational	NF1	4763	downregulated	panobinostat results in decreased expression of NF1 mRNA	17q11.2	A21037

Displaying entries 56401 - 56425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability